The Clinical Infrastructure Core is an indispensable component of the SCCOR proposal. It is the unifying link that serves each Project in a very specific manner by providing blood for DNA analysis and assorted biochemistry determinations. Just as importantly, the Clinical Infrastructure Core collects, collates, files and retrieves all clinical data, thereby matching each scientific analysis to key clinical information. Moreover, the Clinical Infrastructure Core is responsible for recruiting patients, controls, and unique families for longitudinal study. It is also responsible for the systematic follow-up of these patients and their families. In reality, this is an enormous task, requiring the multiple interactions with patients, families, physicians, research nurses, scientists, IRBs and administrators. Thousands of samples will be acquired, stored, retrieved and analyzed. An exceptionally large database of clinical, demographic, angiographic, electrocardiographic and echocardiographic material will be generated and maintained. The group at the Cleveland Clinic has already assembled such an organization on site in the form of GeneBank and GeneQuest. We have now several years of experience with these two large and important data repositories, generously maintained by strong institutional support. We have space and a large cadre of research nurses, computers, technicians and some physicians to operate this labor-intensive infrastructure. Over time, its operational aspects have improved, and important new data on genes and coronary artery disease are currently emerging. We now have an opportunity with the SCCOR to expand our research goals and further link our clinical phenotype information in the data banks to the genetic and molecular pathophysiology of coronary artery disease. The Clinical Infrastructure Core is clearly essential to this end. We believe that under the able leadership of Drs. Gary Francis and Stephen Ellis and our many dedicated personnel, that we can leverage our unique experience with GeneBank and GeneQuest to focus on new and tightly integrated SCCOR projects designed to explore and better understand the genetics of coronary artery disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL077107-03
Application #
7786010
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
2007-01-01
Budget End
2007-12-31
Support Year
3
Fiscal Year
2007
Total Cost
$568,756
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Xu, Huichun; Dorn 2nd, Gerald W; Shetty, Amol et al. (2018) A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African Americans. J Pers Med 8:
Kim, Dae Joong; Christofidou, Elena D; Keene, Douglas R et al. (2015) Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. Mol Biol Cell 26:2640-54
Lauer, Michael S (2014) Personal reflections on big science, small science, or the right mix. Circ Res 114:1080-2
Gao, Hanxiang; Li, Lin; Rao, Shaoqi et al. (2014) Genome-wide linkage scan identifies two novel genetic loci for coronary artery disease: in GeneQuest families. PLoS One 9:e113935
Sossey-Alaoui, Khalid (2013) Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis. Semin Cell Dev Biol 24:287-97
Tang, W H Wilson; Shrestha, Kevin; Tong, Wilson et al. (2013) Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction. Transl Res 162:26-33
Stenina-Adognravi, Olga (2013) Thrombospondins: old players, new games. Curr Opin Lipidol 24:401-9
Tang, W H Wilson; Shrestha, Kevin; Wang, Zeneng et al. (2013) Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. J Card Fail 19:87-93
Shao, Zhili; Wang, Zeneng; Shrestha, Kevin et al. (2012) Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. J Am Coll Cardiol 59:1150-8
Timur, A A; Murugesan, G; Zhang, L et al. (2012) P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol 34:473-83

Showing the most recent 10 out of 120 publications